Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent

BACKGROUND: Medications used to augment lactation increase prolactin secretion but can have intolerable side effects. We examined the biological activity of recombinant human prolactin (r-hPRL) as preliminary data for its use to augment lactation. METHODS: Healthy, non-postpartum women (n = 21) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Page-Wilson, Gabrielle, Smith, Patricia C, Welt, Corrine K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950489/
https://www.ncbi.nlm.nih.gov/pubmed/17650319
http://dx.doi.org/10.1186/1746-4358-2-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950489/
https://www.ncbi.nlm.nih.gov/pubmed/17650319
http://dx.doi.org/10.1186/1746-4358-2-10

Ejemplares similares